ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody FinanzNachrichten Wed, 05 Dec 2007 4:16 AM PST TORONTO, Dec. 5 /PRNewswire-FirstCall/ -- ARIUS Research Inc. (TSX: ARI), a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that it has entered into a manufacturing supply and technology transfer agreement for its CD44 Cancer Stem Cell antibody with Avid ( Nachrichten ) Bioservices, a company providing cGMP manufacturing services for the ... | ARIUS announces manufacturing agreement with Avid Bioservices for CD44 Cancer Stem Cell antibody CNW Group via Yahoo! Finance Wed, 05 Dec 2007 4:00 AM PST ARIUS Research Inc. , a biotechnology company discovering and developing the next wave of antibody therapeutics, today announced that it has entered into a manufacturing supply and technology transfer agreement for its CD44 Cancer Stem Cell antibody with Avid Bioservices, a company providing cGMP manufacturing services for the biotechnology and biopharmaceutical industries. | Bone Marrow Cell Transplants Help Nerve Regeneration Medical News Today Wed, 05 Dec 2007 5:05 AM PST A study carried out by researchers at the Kyoto University School of Medicine and published in the current issue of CELL TRANSPLANTATION (Vol.16 No. 8) has shown that when transplanted bone marrow cells (BMCs) containing adult stem cells are protected by a 15mm silicon tube and nourished with bio-engineered materials, they successfully help regenerate damaged nerves. [click link for full article] | Validating The Feasibility Of Using Stem Cells For Drug Discovery. DrugDiscoveryOnline Wed, 05 Dec 2007 2:30 AM PST I-STEM is a new organisation formed by INSERM, the French national institute of health, with AFM, the French muscular dystrophy association, to validate the feasibility of using human embryonic stem cells for therapeutics, both through cell therapy and in drug discovery | 'Mini-transplant' patients' do as well using unrelated donors Cancerfacts.com Wed, 05 Dec 2007 0:42 AM PST SEATTLE – Dec. 4, 2007 – People who undergo "mini-stem cell transplants," for leukemia, lymphoma and other blood cancers using a matched unrelated donor have as good outcomes as similar patients who receive their stem cells from an related donor, a new study shows. | Hot science fields look to bring in college graduates Arizona Daily Wildcat Wed, 05 Dec 2007 0:48 AM PST As the world turns its attention to the pressing issues of climate change, advances in communication technology and stem cell research, college students and recent college graduates looking to thumb the cutting edge of rapidly expanding research fields are faced with a host of exciting options. | | |
|